STOML3

STOML3 (stomatin-like protein-3) is an integral membrane protein of sensory neurons that sensitizes mechanically gated ion channels by tuning the mechanical properties of the lipid bilayer (PMID:26443885). It binds cholesterol and partitions into cholesterol-rich lipid rafts, where it is required to maintain membrane stiffness; loss of STOML3 or depletion of cholesterol interdependently attenuates the sensitivity of Piezo1 and Piezo2 channels in heterologous systems (PMID:26443885). STOML3 forms oligomers that are essential for setting the sensitivity of mechanically gated currents, and small-molecule inhibitors of oligomerization reversibly silence mechanoreceptors and reverse mechanical hypersensitivity in nerve-injury and diabetic-neuropathy models, identifying oligomerization as a druggable node (PMID:27941788). STOML3 also associates physically with stomatin and ASIC subunits within a mobile Rab11-positive vesicle pool, with an N-terminal hydrophobic region directing vesicular localization and controlling acid-gated currents; uncoupling these vesicles from microtubules drives STOML3 into the plasma membrane and increases acid-gated currents (PMID:22773952). Beyond touch, STOML3 is enriched in olfactory cilia where it associates with adenylyl cyclase type III and caveolin-1 in lipid-raft membranes and modulates cAMP-dependent odorant transduction (PMID:12122055), and STOML3-null olfactory neurons show a transduction-level deficit in spontaneous and evoked firing (PMID:33637538). STOML3 is further required for peripheral functional mechanosensory plasticity after nerve regeneration without affecting central anatomical plasticity (PMID:40163784).

1. 2002 Medium

   Established the first cellular context for STOML3 by showing it operates within a lipid-raft signaling assembly in olfactory cilia, linking it to cAMP-based sensory transduction.

   Evidence Immunoprecipitation from olfactory cilia membrane fractions, lipid-raft fractionation, and antibody-stimulated cAMP assays

   PMID:12122055

   Open questions at the time

   • Direct vs. indirect association with adenylyl cyclase III and caveolin-1 not resolved
   • No in vivo loss-of-function test of the cAMP modulation
   • Single lab with limited mechanistic follow-up
2. 2012 High

   Defined STOML3 as part of a stomatin/ASIC complex sequestered in mobile vesicles, showing that trafficking governs how much STOML3 reaches the surface to regulate acid-gated currents.

   Evidence Reciprocal Co-IP, live-cell vesicle imaging, N-terminal deletion mutagenesis, Rab11 co-localization, and microtubule-uncoupling electrophysiology in DRG neurons and CHO cells

   PMID:22773952

   Open questions at the time

   • Molecular machinery linking the N-terminal hydrophobic region to vesicle targeting unknown
   • Stoichiometry of the STOML3–stomatin–ASIC complex not determined
3. 2012 Low

   Raised a candidate disease association by correlating STOML3 amplification with mesenchymal differentiation in gliosarcoma, though without a functional test.

   Evidence Array CGH, qPCR for amplification across 64 gliosarcoma cases, and IHC for STOML3 protein

   PMID:22538188

   Open questions at the time

   • Correlative genomics with no functional experiment on STOML3 in tumor cells
   • Causal role of amplification in mesenchymal differentiation untested
   • No mechanistic link to mechanosensory function established
4. 2015 High

   Resolved how STOML3 sensitizes mechanotransduction by demonstrating it binds cholesterol and sets membrane stiffness, mechanically coupling lipid-raft physics to Piezo1/Piezo2 gating.

   Evidence Cholesterol depletion, atomic force microscopy of membrane mechanics, Piezo electrophysiology in heterologous systems, and a Stoml3 knockout mouse

   PMID:26443885

   Open questions at the time

   • Structural basis of cholesterol binding not defined
   • Direct physical interaction between STOML3 and Piezo channels not established
5. 2016 High

   Identified STOML3 oligomerization as the functional unit controlling mechanosensitivity and validated it as a pharmacological target for reversing pathological mechanical hypersensitivity.

   Evidence Small-molecule oligomerization inhibitor screens, sensory-neuron electrophysiology, in vivo mechanoreceptor recordings, and behavioral assays in nerve-injury and diabetic-neuropathy mouse models

   PMID:27941788

   Open questions at the time

   • Structure of the STOML3 oligomer unresolved
   • Whether oligomerization acts via membrane mechanics or direct channel contact unclear
6. 2021 Medium

   Extended STOML3's sensory role to olfaction in vivo by localizing it to the cilia/knob and showing knockout produces a transduction-level firing deficit.

   Evidence Loose-patch recordings and immunolocalization in Stoml3 knockout olfactory sensory neurons

   PMID:33637538

   Open questions at the time

   • Molecular target of STOML3 in the olfactory transduction cascade not pinpointed
   • Single lab; relationship to the 2002 adenylyl cyclase III link not directly tested
7. 2025 Medium

   Demonstrated a developmental/regenerative requirement for STOML3, showing it is needed for peripheral functional mechanosensory plasticity but dispensable for central anatomical plasticity.

   Evidence Cross-anastomosis nerve regeneration model with in vivo afferent recordings and central projection tracing in Stoml3 knockout mice

   PMID:40163784

   Open questions at the time

   • Mechanism dissociating functional from anatomical plasticity unknown
   • Whether the deficit reflects membrane-mechanics tuning or trafficking not resolved
   • Single lab

• How STOML3 oligomers, cholesterol binding, and vesicular trafficking are coordinated to physically engage Piezo and ASIC channels remains unresolved.
• No structure of STOML3 alone or in oligomeric/channel complex
• Direct STOML3–Piezo interaction unproven
• Mechanism of Rab11-vesicle regulation of surface delivery undefined